|
|
|
|
|
PARIS, FRANCE, 2023年9月12日 - (亞太商訊) - Ad Scientiam, a global leader in digital biomarkers, has announced a partnership with Sanofi to launch MS-DETECT, an international, multicenter, longitudinal study. MS-DETECT aims to evaluate the ability of MSCopilot(R), a medical software device, to detect early signs of disability worsening in people with multiple sclerosis (PwMS). The study will draw upon Ad Scientiam's expertise in MS and is financially supported by Sanofi.
Multiple Sclerosis (MS) is a chronic immune-mediated disease of the central nervous system that affects 2.8 million people worldwide. The disease is characterized by early inflammatory demyelination and subsequent neurodegeneration. Current clinical evaluation of PwMS relies mainly on the Expanded Disability Status Scale (EDSS), which has several limitations. To improve on these assessments, Ad Scientiam has developed MSCopilot(R), a software medical device that addresses four dimensions: ambulation/mobility, upper extremity function, cognition, and low-contrast visual acuity.
MS-DETECT's main objective is to determine MSCopilot(R)'s ability to identify subtle and early disability worsening. This will be performed by evaluating MSCopilot(R) individual and/or composite scores as compared to the Multiple Sclerosis Functional Composite (MSFC) and the EDSS.
"MS-DETECT is a pioneering large-scale longitudinal study that explores digital biomarkers for the early detection of disease progression. This study will provide important data to both clinicians and people living with MS," according to Dr. Saad Zinai, Chief Medical Officer at Ad Scientiam.
"Disability worsening in MS has been recently redefined and we now know that this progression can occur independently of relapses. With MS-DETECT, we have an opportunity to develop a digital solution to help detect and monitor the effects of smoldering disease, and evolve treatment goals for MS patients," explains Su-Peing Ng, Global Head of Medical Affairs - Specialty Care at Sanofi.
The study also aims to assess the MSCopilot(R) performance, safety, usability and satisfaction with the solution.
"Disease progression can be hard to detect in routine practice. I believe these novel digital biomarkers are key to help clinicians make appropriate treatment decisions and, ultimately, improve patients' care," said Prof. Patrick Vermersch (Lille, France), Coordinating Investigator and Chairman of the Study Steering Committee.
The MS-DETECT study will include 314 PwMS and will be conducted in the United States, Canada, Germany, Italy, Spain, Denmark and France. Several investigative sites have already been initiated in North America and Europe and first patients are expected to participate in the study during Q3 2023.
Check our LinkedIn, Facebook, Instagram pages or visit adscientiam.com
Contact Information
Saad Zinai
Chief Medical Officer
szinai@adscientiam.com
+33768008666
Matthieu Lamy
President
mlamy@adscientiam.com
+33768008666
話題 Press release summary
http://www.acnnewswire.com
From the Asia Corporate News Network
Copyright © 2026 ACN Newswire. All rights reserved. A division of Asia Corporate News Network
|
|
|
|
|
|
 |
|
Latest Press Releases
AmplifiX Releases Comprehensive Sector Report on the Rapid Acceleration of Real-World Asset (RWA) Tokenization
Jan 21, 2026, 23:00 HKT/SGT
|
|
|
TANAKA PRECIOUS METAL TECHNOLOGIES to Exhibit Advanced Precious Metal Materials for Medical Device Components at MD&M West 2026
Wednesday, January 21, 2026 9:00:00 PM
|
|
|
Honda to Discontinue Production of Fuel Cell Systems at Fuel Cell System Manufacturing LLC in the U.S.
Wednesday, January 21, 2026 4:44:00 PM
|
|
|
Notice regarding the dissolution of the joint venture in the home elevator business
Wednesday, January 21, 2026 4:04:00 PM
|
|
|
Eisai Listed as a Global 100 Most Sustainable Corporation for the Tenth Time
Wednesday, January 21, 2026 3:44:00 PM
|
|
|
MHI and ITB Deepen Research Collaboration on Ammonia-Based Clean Power in Indonesia
Wednesday, January 21, 2026 3:37:00 PM
|
|
|
Asian Financial Forum opens next Monday with a fresh perspective and new tagline, Finance Empowering Business
Wednesday, January 21, 2026 1:30:00 PM
|
|
|
Exito Drives India's Digital-First Revolution with the Flagship 43rd Digital Transformation Summit - India 2026
Jan 21, 2026, 13:00 HKT/SGT
|
|
|
MHI-TC Delivers Self-Propelled Mobile Seaport Passenger Boarding Bridge to Yokohama City, Entering Service on January 13th
Wednesday, January 21, 2026 10:02:00 AM
|
|
|
Dowway Proposes Rebranding with a New Name 'Defeng Solife'
Jan 21, 2026, 09:51 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
